From the Hertie-Institute for Clinical Brain Research (A.C.O., J.R., L.S., R.S.), Department of Neurodegenerative Diseases, University of Tübingen, Germany; Bogazici University (E.B., B.O.), Department of Molecular Biology and Genetics, Istanbul; Tepecik Research and Training Hospital (L.O., Y.Z.), Clinics of Neurology, Izmir, Turkey; Diagnostic and Interventional Neuroradiology (T.L., B.B.), Department of Radiology, University Hospital Tübingen; German Research Center for Neurodegenerative Diseases (DZNE) (J.R., R.S., L.S.), Tübingen, Germany; Dr. John T. Macdonald Foundation Department of Human Genetics and John P. Hussman Institute for Human Genomics (A.P.R., M.A.G., S.Z., R.S.), University of Miami Miller School of Medicine, FL; Department of Neurology (D.T.), University of Duisburg-Essen; and Department of Physics E22 (Biophysics) (G.W.), Technical University Munich, Garching, Germany.
Neurology. 2014 Jun 3;82(22):2007-16. doi: 10.1212/WNL.0000000000000479. Epub 2014 May 7.
To identify a novel disease gene in 2 families with autosomal recessive hereditary spastic paraplegia (HSP).
We used whole-exome sequencing to identify the underlying genetic disease cause in 2 families with apparently autosomal recessive spastic paraplegia. Endogenous expression as well as subcellular localization of wild-type and mutant protein were studied to support the pathogenicity of the identified mutations.
In 2 families, we identified compound heterozygous or homozygous mutations in the kinesin gene KIF1C to cause hereditary spastic paraplegia type 58 (SPG58). SPG58 can be complicated by cervical dystonia and cerebellar ataxia. The same mutations in a heterozygous state result in a mild or subclinical phenotype. KIF1C mutations in SPG58 affect the domains involved in adenosine triphosphate hydrolysis and microtubule binding, key functions for this microtubule-based motor protein.
KIF1C is the third kinesin gene involved in the pathogenesis of HSPs and is characterized by a mild dominant and a more severe recessive disease phenotype. The identification of KIF1C as an HSP disease gene further supports the key role of intracellular trafficking processes in the pathogenesis of hereditary axonopathies.
在 2 个常染色体隐性遗传性痉挛性截瘫(HSP)家族中鉴定一种新的疾病基因。
我们使用全外显子组测序在 2 个表现为常染色体隐性痉挛性截瘫的家族中鉴定潜在的遗传疾病原因。研究内源性表达以及野生型和突变蛋白的亚细胞定位,以支持鉴定出的突变的致病性。
在 2 个家族中,我们发现驱动蛋白基因 KIF1C 的复合杂合或纯合突变导致 58 型遗传性痉挛性截瘫(SPG58)。SPG58 可伴有颈肌张力障碍和小脑共济失调。杂合状态下的相同突变导致轻度或亚临床表型。SPG58 中的 KIF1C 突变影响涉及三磷酸腺苷水解和微管结合的结构域,这是该微管基运动蛋白的关键功能。
KIF1C 是第三个参与 HSP 发病机制的驱动蛋白基因,其特征是显性轻度和隐性重度疾病表型。KIF1C 作为 HSP 疾病基因的鉴定进一步支持细胞内运输过程在遗传性轴索病变发病机制中的关键作用。